Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of clopidogrel and prasugrel with and without aspirin on hemostatic activation at the site of plug formation
2010-019643-19Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Dec 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of clopidogrel, prasugrel and aspirin in coronary arteriosclerosis and acute coronary syndrome (ACS) (5 arms), sponsored by Medical University of Vienna. Primary endpoint: β-thromboglobulin (β-TG) concentration in shed blood plasma. Started Dec 2010; status: completed.
02
Drugs
clopidogrelprasugrelaspirin
03
Conditions
coronary arteriosclerosisacute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2010-019643-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019643-19.